optimizerx.com (OPRX) Value Adjusted for Debt and Cash

Corporate company logo of optimizerx.com (OPRX)

The market trend for OptimizeRx Corporation (OPRX) shares on the GURU.Markets platform, where the Enterprise Value stands at 166.03, reflects the business dynamics within the med-IT sector. Demand for the company's services is moderately dependent on economic cycles, as the digitalization of healthcare offsets potential cost-cutting by pharma behemoths. Growth is driven by AI implementation and the online shift of advertising spend, while a subscription model and a broad pool of corporate clients ensure stability.

OPRX OptimizeRx Corp.: Enterprise Value in the range 11/23/2025 - 10/28/2026

Analytical breakdowns for OptimizeRx Corporation

- price and consensus price forecast:
Quote Chart OptimizeRx Corp|OPRX - Price Target Chart
- market capitalization data:
Market Value OptimizeRx|OPRX - Real Price to Acquire Entire Company
- book capitalization data:
Equity per Share OptimizeRx|OPRX - Book Capitalization|Market Capitalization to Book Value optimizerx.com|OPRX - Cumulative Company Assets
- debt and liquidity data:
Aggregate Debt to Capital OptimizeRx Corporation|OPRX - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital optimizerx.com|OPRX - Company Debts|Debt to Book Value OptimizeRx|OPRX - Company Long-Term Debts|Short-Term Debt OptimizeRx
Fundamental company valuation:OPRX (OptimizeRx Corp)
Mass-produced product of optimizerx.com

To minimize risks, it is essential for investors to assess the real value of OptimizeRx Corporation (OPRX) by summing market capitalization with net debt, as reflected in this enterprise value chart. The high operational resilience of the AI-powered digital medical marketing platform allows this trend to be interpreted as an indicator of the balance between leveraged capital and the fundamental value of the company's assets.

Direct competitors

Veeva Systems - Full Business Value|Total Company Value Doximity Corp (DOCS)|HealthEquity Building (HQY) - Value Adjusted for Debt and Cash|Real Price to Acquire Entire Company Waystar Holding Corp.|corvel.com (CRVL) - Business Value|PRVA: Enterprise Value|Company Buyout Price Huron Consulting Group Inc. (HURN)|Real Price to Acquire Entire Company Certara Corp|Aggregate Business Value Omnicell Health OMCL|Real Price to Acquire Entire Company GoodRx Holdings, Inc.|schrodinger.com - Value Adjusted for Debt and Cash|PHR: Total Company Value|OMDA - Real Price to Acquire Entire Company|Enterprise Value EVH|HealthStream Learning (HSTM) - Total Enterprise Value|Enterprise Value Definitive Healthcare (DH)|Business Value CCSI|agilon health - Total Company Value|Total Enterprise Value ABSI (Absci Corp)|SoYoung (SY) - Total Company Value|NRC - Full Business Value|Real Price to Acquire Entire Company Spok Holdings, Inc. SPOK|TBRG - Aggregate Business Value|Simulations Plus - Enterprise Value|SOPH (SOPHiA GENETICS) - Company Buyout Price|Total Company Value HCAT|Real Price to Acquire Entire Company CareCloud Corp|RSSS (Research Solutions, Inc.) - Enterprise Value|Company Buyout Price dlhcorp.com DLHC|OneMedNet (ONMD) - Real Price to Acquire Entire Company|Full Business Value Scienture Holdings SCNX|HCTI (Healthcare Triangle Corp) - Enterprise Value|ISPC: Total Enterprise Value|Total Company Value bullfrogai.com BFRG|Value Adjusted for Debt and Cash scworx.com|Real Price to Acquire Entire Company MSP Recovery (MSPR)|Business Value iCoreConnect Corp (ICCT)|TRxADE (MEDS) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Orgenesis Corporation (ORGS)|R1 RCM - Enterprise Value|sharecare.com - Real Price to Acquire Entire Company|STRM (Streamline Health) - Total Company Value|SYRA: Total Enterprise Value|Total Company Value apollomed.net AMEH|MODN (Model N Corporation) - Value Adjusted for Debt and Cash|Total Company Value NextGen Healthcare NXGN